In line with these risk factors, polymorphisms in important metabolic genes, such as patatin-like phospholipase domain-containing protein 3 [PNPLA3]) involved in the pathogenesis of NAFLD, have a reported 12-fold risk for HCC6–9. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.